Cardiopulmonary coupling derived sleep quality is associated with improvements in blood pressure in patients with obstructive sleep apnea at high cardiovascular risk

Reference:

Magnusdottir S, Hilmisson H, Thomas RJ. Cardiopulmonary coupling-derived sleep quality is associated with improvements in blood pressure in patients with obstructive sleep apnea at high-cardiovascular risk. J Hypertens 2020; 38(11):2287-2297. DOI:10.1097/HJH.0000000000002553

Objectives: Investigate if changes in objective sleep quality index (SQI) assessed through cardiopulmonary-coupling analysis impacts blood pressure (BP) in patients with obstructive sleep apnea at high-cardiovascular risk.

Conclusion: In patients with poor sleep quality at baseline (SQI <55), CPAP-therapy improves MAP24 -3.02 (p=0.030) and MAPSleep -5.00 (p=0.001) but in in patients with good baseline-SQI (SQI>55 increased sleep fragmentation (eLFCBB) relative to HLSE-therapy with a difference in margin of 5.48 (p=0.011) and no significant. Significant differences are observed comparing patients that Improved-SQI (SQIBaseline<55,SQIFollow-up≥55) and Declined-SQI (SQIBaseline≥55,SQIFollow-up<55)  in MAP24 -4.87 (p=0.046) and MDP24 -4.42 (p=0.026) as well as  MAPWake -6.36 (p=0.015), MSPWake -7.80 (p=0.048) and MDPWake-5.64 (p=0.009), respectively.

 

Practical Significance: Improved SQI reflects the magnitude of positive effect on blood pressure which is reached mostly through initiation of CPAP-therapy in patients with compromised baseline sleep quality. Improved sleep quality positively impacts blood pressure, both during sleep and wake.

View Publication

Cardiopulmonary coupling derived sleep quality is associated with improvements in blood pressure in patients with obstructive sleep apnea at high cardiovascular risk

Reference:

Magnusdottir S, Hilmisson H, Thomas RJ. Cardiopulmonary coupling-derived sleep quality is associated with improvements in blood pressure in patients with obstructive sleep apnea at high-cardiovascular risk. J Hypertens 2020; 38(11):2287-2297. DOI:10.1097/HJH.0000000000002553

Objectives: Investigate if changes in objective sleep quality index (SQI) assessed through cardiopulmonary-coupling analysis impacts blood pressure (BP) in patients with obstructive sleep apnea at high-cardiovascular risk.

Conclusion: In patients with poor sleep quality at baseline (SQI <55), CPAP-therapy improves MAP24 -3.02 (p=0.030) and MAPSleep -5.00 (p=0.001) but in in patients with good baseline-SQI (SQI>55 increased sleep fragmentation (eLFCBB) relative to HLSE-therapy with a difference in margin of 5.48 (p=0.011) and no significant. Significant differences are observed comparing patients that Improved-SQI (SQIBaseline<55,SQIFollow-up≥55) and Declined-SQI (SQIBaseline≥55,SQIFollow-up<55)  in MAP24 -4.87 (p=0.046) and MDP24 -4.42 (p=0.026) as well as  MAPWake -6.36 (p=0.015), MSPWake -7.80 (p=0.048) and MDPWake-5.64 (p=0.009), respectively.

 

Practical Significance: Improved SQI reflects the magnitude of positive effect on blood pressure which is reached mostly through initiation of CPAP-therapy in patients with compromised baseline sleep quality. Improved sleep quality positively impacts blood pressure, both during sleep and wake.

View Publication